If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Trading Update

15 May 2020 07:00

RNS Number : 9837M
Zoetic International PLC
15 May 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

Zoetic International plc

("Zoetic" or the "Company")

15 May 2020

 

Trading Update

 

Appointment of Company Secretary

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD and natural resources company, is pleased to provide the following update on its operations.

 

Highlights

 

· Outline agreement reached on a further US multi-State distribution contract for Chill

· Significant further cost reductions achieved within the Oil & Gas Division and progress towards exit from the industry

· Testing commenced with another US University on high quality seeds

· International seed distribution agreement discussions are underway

· Zoetic brand short-listed for Top Sante Skincare awards

 

 

Current Trading and Prospects

 

The period since the end of the last financial year, on 31 March 2020, has seen pivotal changes for the Company in its progress away from its origins in the oil & gas sector and towards its future as a vertically-integrated CBD and hemp business. The new board of directors (the "Board") announced on 29 April 2020 has continued and accelerated the progress already made on this path.

 

The strategic partnership with the Schrader Family continues to develop successfully, combining their position as both the Company's largest shareholder (13.32%) and through its US-wide convenience store network of distribution businesses, Ox Distributing LLC, the Company's key marketing channel for the Chill brand within the USA. This has resulted in outline terms being agreed on a new multi-State distribution agreement to place Chill brand products in US convenience stores, which is expected to be signed this quarter.

 

The Board can also confirm that the Schrader Family has made the payment due on 30 April 2020 for the loan note announced on 26 March 2020 and the Board is confident the Schrader family will continue to be supportive and instrumental in the growth of the Company.

 

While the current Covid-19 pandemic is significantly limiting footfall in convenience stores in many US States, the Board believes the distribution agreements already agreed and those close to signing will lead to a substantial increase in sales of Chill brand products within the USA. The brand's focus on the tobacco-replacement market is expected by the Board to be especially attractive as health concerns are exacerbated by the current pandemic. The Board has commenced negotiations for distribution of the Chill brand in two overseas markets, in addition to others within the USA, and hopes to conclude further significant distribution contracts during the first quarter of the current financial year.

 

The Zoetic brand, which is currently focussed on the UK market, has recently received recognition for its innovative use of CBD in beauty products by being shortlisted for the "Top Sante Skincare Awards" in the UK. The brand continues to generate excitement in its corresponding product categories.

 

The prospective wholesale hemp seed business has made significant progress towards commercialisation. Firstly, the Company is engaged with a major US University, one of the country's leading centres of agri-science, to identify particularly attractive seed strains within its product offerings. Concurrently with this programme, negotiations have commenced on distribution agreements for seeds both in the USA and overseas. During the Covid-19 pandemic, Zoetic will continue to strengthen the credibility of its high-quality feminised seeds through various partnerships and third-party testing. 

 

The Board has continued a substantial cost-reduction exercise within the Oil & Gas business, with further savings expected by the end of the first quarter of the current financial year. There are no revenues currently being produced by this business due the current low levels of domestic oil prices in the USA. The Board continues to seek an exit from this business and several negotiations are currently in progress. In addition, the Board is progressing additional cost-savings within the UK.

 

Company Secretary

 

The Board is pleased to announce the appointment of MSP Secretaries Ltd as company secretary.

 

Antonio Russo, Co-CEO of Zoetic, commented, "We cannot be more pleased with the amount of demand we are receiving from large distributors for the Chill brand. When this pandemic is over, we will be well positioned to expand the brand's distribution footprint both in the US and internationally."

 

Trevor Taylor, Co-CEO of Zoetic, commented, "The recent restructuring is providing an immediate positive impact on the Company. Under the new structure decisive strategic decisions are being made at a pace much more aligned with shareholder expectations."

 

**ENDS**

 

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss

Nick Naylor

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBZLLFBELLBBQ
Date   Source Headline
22nd Jun 20179:00 amRNSPrice Monitoring Extension
21st Jun 20177:30 amRNSFinal Results
21st Jun 20177:00 amRNSHighlands' First DT Ultravert Patent Issued
3rd May 201710:00 amRNSIssue of Shares
10th Apr 20177:00 amRNSApproval of Permit; Update on East Denver Drilling
20th Mar 20178:30 amRNSHolding(s) in Company
20th Mar 20178:25 amRNSIssue of Shares
10th Mar 20177:00 amRNSExpanded Renegade Agreement, East Denver
26th Jan 20174:30 pmRNSDefinitive Helios Two Gas Analysis Results
9th Jan 20177:00 amRNSIndependent analyses of core projects
19th Dec 20167:00 amRNSExtension of East Denver Farm-in Agreement
16th Dec 20167:00 amRNSFurther Farm-in Agreement In East Denver Project
24th Nov 20167:00 amRNSInterim Results
28th Oct 20167:00 amRNSHelios Two Drilling and Development Update
26th Oct 20167:00 amRNSExecutes Re-Fracking Agreement for DT Ultravert
20th Oct 20162:05 pmRNSHolding(s) in Company
20th Oct 20162:05 pmRNSHolding(s) in Company
20th Oct 20162:00 pmRNSIssue of Shares
19th Oct 20167:00 amRNSDT Ultravert Testing Update
30th Sep 20162:45 pmRNSDisposal of Warrants
30th Sep 20167:00 amRNSFirst Helios Two Well Drilled and Completed
30th Sep 20167:00 amRNSSchlumberger DT Ultravert Agreement Update
21st Sep 201611:10 amRNSIssue of Shares
20th Sep 20162:00 pmRNSResult of AGM
20th Sep 20167:00 amRNSOperations Update
19th Sep 20167:00 amRNSCommences Drilling at Helios Two, Montana
16th Sep 20167:00 amRNSHoldings in Company
16th Sep 20167:00 amRNSHoldings in Company
16th Sep 20167:00 amRNSIssue of Shares
2nd Sep 20164:55 pmRNSHoldings in Company
2nd Sep 20164:45 pmRNSIssue of Shares and Disposal of Warrants
17th Aug 20167:00 amRNSHelios Two Leasing and Development Update
11th Aug 20167:00 amRNSNotice of AGM
28th Jul 20167:00 amRNSExercise of Warrants
25th Jul 20167:00 amRNSDenver Julesburg Basin Farm-In Agreement
18th Jul 20167:00 amRNSHelios Two Leasing and Development Update
11th Jul 20169:05 amRNSSecond Price Monitoring Extn
11th Jul 20169:00 amRNSPrice Monitoring Extension
11th Jul 20167:00 amRNSUpdate on the Helios Two Transaction
11th Jul 20167:00 amRNSStatement re Termination of Agreement
8th Jul 20167:00 amRNSIssue of Shares
1st Jul 20167:00 amRNSIssue of Shares
28th Jun 20167:00 amRNSIssue of Shares
27th Jun 20163:30 pmRNSUpdated Corporate Presentation
27th Jun 20167:00 amRNSHelios Two: Receipt of Competent Persons Report
22nd Jun 20167:00 amRNSIssue of Shares
21st Jun 20162:05 pmRNSSecond Price Monitoring Extn
21st Jun 20162:00 pmRNSPrice Monitoring Extension
17th Jun 20167:00 amRNSUpdate on Disposal of Warrants
15th Jun 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.